Risk of falls in postmenopausal women treated with romosozumab: Preliminary indices from a meta-analysis of randomized, controlled trials

OBJECTIVES: Falls are the well-known risk factor for osteoporotic fractures and some medications can increase the risk of falls. Therefore, the aim of our study is to evaluate the effect of romosozumab on risk of falls in postmenopausal women. METHODS: Studies were searched on PubMed, Cochrane Centr...

Descripción completa

Detalles Bibliográficos
Autores principales: Möckel, Luis, Bartneck, Matthias, Möckel, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093685/
https://www.ncbi.nlm.nih.gov/pubmed/32226829
http://dx.doi.org/10.1016/j.afos.2020.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093685/
https://www.ncbi.nlm.nih.gov/pubmed/32226829
http://dx.doi.org/10.1016/j.afos.2020.02.003

Ejemplares similares